Handbook of clinical neurologyHumansNeuromyelitis OpticaMyelin-Oligodendrocyte GlycoproteinImmunotherapyAutoantibodies
Immunotherapies for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.
Itay Lotan, Monique Anderson, Michael Levy
Published: 202610.1016/B978-0-323-90887-0.00015-8
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are rare autoimmune neuroinflammatory disorders of the central nervous system (CNS) characterized by recurrent attacks of optic…
Preview only. Read the full abstract at the source